NUR 610 Module 3 Genomics and Infectious Disease Ethics Discussion Example

Discussion Board: Genomics and Infectious Disease

The Genome Can Draw the Arrow: Tuberculosis Sequencing, Transmission and Blame in a Shelter Outbreak

Initial Post

In my composite example, a Phoenix shelter has six tuberculosis cases over eight months. Traditional genotyping shows the isolates belong to the same strain, but that strain is common in the region, so it cannot show whether the cases are part of one chain of transmission. Whole-genome sequencing changes that. In a study from the UK Midlands, sequencing of 390 isolates showed that closely related strains could be separated by small numbers of genetic differences, allowing investigators to rule transmission in or out more precisely and even to suggest likely direction of spread in some clusters (Walker et al., 2013).

This precision is a public health gain. It can focus contact investigations on people truly linked, avoid unnecessary screening of others, and identify a superspreading setting such as a particular dormitory. In our composite outbreak, sequencing showed five of six cases were closely linked and that the earliest case was likely a long-term resident who had been coughing for months.

But the readings this week made me think about what it means to draw an arrow from one person to another. Earlier models of disease causation, such as the nineteenth-century debate over whether tuberculosis was hereditary or infectious, shaped how societies treated patients, sometimes with stigma and isolation. Geller et al. (2014) argue that genomic information about pathogens and hosts raises ethical, legal and social questions for public health, including balancing benefits and harms between individuals and the community, threats to privacy and autonomy, and fair distribution of resources. When sequencing points to a likely source, that person can be blamed, especially in a shelter where residents already face stigma.

I think three practices help. First, use sequencing results to guide public health action, not to assign fault; the question is where transmission is happening, not who is responsible. Second, protect identities carefully, since in a small setting even anonymous results can reveal the source. Third, focus the response on conditions that drive transmission, such as crowding, poor ventilation and delayed diagnosis, which were the real causes in our case. The public health ethics framework from Kass (2001) fits here: the burden of being identified as a source should be minimized, and the program should address injustices, such as crowded shelters, rather than add to them.

Genomics gives public health a sharper tool, but sharper tools require more careful hands.

Reply to Elena

Elena, your post about COVID-19 variant sequencing raised a related issue at the population level: when a variant is named for a country, people from that country face blame. The shift to naming variants by Greek letters was an attempt to reduce that harm, and I think it parallels what we should do at the individual level in tuberculosis outbreaks. In both cases, the genome tells us how a pathogen moves, not who deserves blame. I appreciated your point that genomic surveillance helped track vaccine escape, which is a strong benefit. I wonder whether sequencing programs for respiratory infections should include explicit communication plans to prevent stigma, built in from the start rather than added after harm occurs. Your example of variant naming suggests that such plans can work when public health agencies take the issue seriously. It would be interesting to compare how different countries handled this. In my own work, I have seen how quickly a rumor about where an outbreak started can spread in a small community, and how hard it is to correct once it does. A communication plan written before results come back would help staff answer questions consistently.

Reply to Darnell

Darnell, you described isolation orders for tuberculosis as the clearest case of restricting rights to protect others. I agree that isolation can be justified for infectious tuberculosis, but your post made me think about how genomics could change that calculation. If sequencing shows that a person's strain is not linked to any other cases, it may support shorter or less restrictive measures for contacts, which reduces the burden on people who were not part of transmission. In that sense, genomics can protect rights as well as restrict them. The concern is that the same data could be used to justify more intrusive measures for people identified as sources. I wonder whether health departments should set rules in advance about how sequencing results can and cannot be used in legal orders. That would give people some assurance that genomic data will not be turned against them. Shelter residents in particular have reason to distrust institutions, and a published policy, explained by outreach workers they already know, might make them more willing to be tested and to name contacts, which is what the investigation needs.

References

Geller, G., Dvoskin, R., Thio, C. L., Duggal, P., Lewis, M. H., Bailey, T. C., Sutherland, A., Salmon, D. A., & Kahn, J. P. (2014). Genomics and infectious disease: A call to identify the ethical, legal and social implications for public health and clinical practice. Genome Medicine, 6(11), 106. https://doi.org/10.1186/s13073-014-0106-2

Kass, N. E. (2001). An ethics framework for public health. American Journal of Public Health, 91(11), 1776-1782. https://doi.org/10.2105/AJPH.91.11.1776

Walker, T. M., Ip, C. L. C., Harrell, R. H., Evans, J. T., Kapatai, G., Dedicoat, M. J., Eyre, D. W., Wilson, D. J., Hawkey, P. M., Crook, D. W., Parkhill, J., Harris, D., Walker, A. S., Bowden, R., Monk, P., Smith, E. G., & Peto, T. E. A. (2013). Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: A retrospective observational study. The Lancet Infectious Diseases, 13(2), 137-146. https://doi.org/10.1016/S1473-3099(12)70277-3